Parata's COVID-19 Response

Chain Drug Review — Tech Talk

The quest for next-generation solutions

By Tom Rhoads, CEO, Parata Systems

Published in Chain Drug Review
August 2011

For an executive, every decision balances risk with reward and acknowledges the status quo can often be the riskiest decision of all. Shrinking margins are putting the squeeze on pharmacy’s operational efficiency, hastened by the government’s plan to add up to 30 million people under the same model as Medicare and Medicaid.

To do nothing in the face of this sea change is to risk obsolescence; the effects of strategies now being considered to balance cost reduction with customer experience will reverberate for years to come…

The full article has now been archived.

Other Stories You May Like